NOVAVAX, INC.

(NVAX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about NOVAVAX, INC.
05/20SECTOR UPDATE : Health Care Stocks Rebound In Final Hour of Friday Trade
MT
05/20SECTOR UPDATE : Health Care Stocks Beginning to Sputter Amid Broader Markets Slide
MT
05/20Novavax Shares Drop After BofA Securities Begins Coverage at Underperform
MT
05/20EMA Starts Evaluation of Booster Dose Usage of Novavax's COVID-19 Vaccine
MT
05/20EMA Starts Evaluating Use Of Booster Dose Of Nuvaxovid In Adults
RE
05/20BofA Securities Initiates Coverage on Novavax With Underperform Rating
MT
05/16Novavax Files for Emergency Use Authorization of COVID-19 Vaccine in Taiwan
AQ
05/11TRANSCRIPT : Novavax, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-..
CI
05/11SECTOR UPDATE : Health Care Stocks Edging Lower Ahead of Wednesday Close
MT
05/11SECTOR UPDATE : Health Care Stocks Still Hanging on for Small Advance
MT
05/11B. Riley Lowers Novavax's Price Target to $181 from $203, Keeps Buy Rating
MT
05/10Wall St slips in choppy trading ahead of inflation data
RE
05/10GLOBAL MARKETS LIVE : Bayer, Sony, AMC, Peloton, Tesla...
05/10Novavax Reports Higher Q1 Results; Shares Slump
MT
05/10WALL STREET STOCK EXCHANGE : A little respite for Wall Street
05/10SECTOR UPDATE : Health Care Stocks Climb Premarket Tuesday
MT
05/10What you need to know about the coronavirus right now
RE
05/10Novavax shares slide 20% on COVID vaccine demand uncertainty
RE
05/09Novavax Reports Higher Q1 Earnings, Revenue; Issues 2022 Revenue Guidance
MT
05/09NOVAVAX : Q1 Earnings Snapshot
AQ
05/09TRANSCRIPT : Novavax, Inc., Q1 2022 Earnings Call, May 09, 2022
CI
05/09Novavax 2022 COVID vaccine deliveries off to slow start, shares drop
RE
05/09Earnings Flash (NVAX) NOVAVAX Posts Q1 Revenue $704M, vs. Street Est of $845.2M
MT
05/09Novavax posts drop in COVID research funding, slow start to 2022 vaccine delivery
RE
05/09Novavax Reports First Quarter 2022 Financial Results and Operational Highlights
PR
05/09Novavax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/09Novavax Submits Variations to Expand Australian and New Zealand Provisional Approval of..
AQ
05/09Novavax COVID-19 Vaccine Nuvaxovid Arrives in Singapore
AQ
05/09COVID vaccine makers shift focus to boosters
RE
05/05Novavax Requests Expanded Authorization of Nuvaxovid COVID-19 Vaccine to Adolescents Ag..
AQ
05/04Novavax to Participate in BofA Securities 2022 Healthcare Conference
PR
05/02Novavax to Host Conference Call to Discuss First Quarter 2022 Financial Results and Ope..
PR
05/02FDA Announces Vaccines and Related Biological Products Advisory Committee Review of Nov..
AQ
04/29Novavax's NVX-CoV2373 To Undergo FDA Committee Review; Shares Climb
MT
04/29US FDA Sets Dates in June to Discuss Use of Pfizer-BioNTech, Moderna COVID-19 Vaccines ..
MT
04/29FDA Announces Vaccines and Related Biological Products Advisory Committee Review of Nov..
PR
04/29FDA Announces Vaccines and Related Biological Products Advisory Committee Review of Nov..
CI
04/29Novavax Shares Jump as FDA Plans Vaccine Review
DJ
04/26B. Riley Lowers Novavax's Price Target to $203 from $250, Notes Relatively Lowered Pene..
MT
04/22SECTOR UPDATE : Health Care Stocks Flat To Lower Premarket Friday
MT
04/22Novavax Starts Dosing in COVID-19 Vaccine Booster Study in Adolescents
MT
04/22Novavax Announces Initiation of COVID-19 Vaccine Booster Study in Adolescents in Phase ..
PR
04/22Novavax Announces Initiation of COVID-19 Vaccine Booster Study in Adolescents in Phase ..
CI
04/21Novavax, Inc. - Initial Results from Novavax COVID-19-Influenza Vaccine Trial are First..
AQ
04/21Taiwan approves second COVID booster dose, infections yet to peak
RE
04/20Novavax's Combined Flu, COVID-19 Vaccine Candidate Shows Potential in Early-Stage Study
MT
04/20Novavax Says Early COVID-Influenza Combo Vaccine Data 'Encouraging'
MT
04/20Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasib..
PR
04/20Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasib..
CI
04/20Novavax Announces Approval of Nuvaxovid COVID-19 Vaccine for Primary and Booster Immuni..
AQ
04/19Novavax Shares Fall 1% Following Nuvaxovid Approval in Japan
DJ
04/19Novavax's Partner Takeda Secures Approval of Nuvaxovid COVID-19 Vaccine in Japan
MT
04/19Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster..
PR
04/19Japan OKs use of vaccine by U.S. firm Novavax
AQ
04/19Japan greenlights Novavax vaccine, shots to start as early as May
AQ
04/19Japan Index Retraces Gains Following Novavax Vaccine Clearance, Yen Decline
MT
04/19Japan approves Novavax as 4th COVID vaccine amid new surge
AQ
04/19Japan approves Novavax COVID-19 vaccine
AQ
04/18Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical..
PR
04/18Novavax to Provide a First Look at Data from Its Covid-19 Influenza Combination Vaccine..
CI
04/17Main events scheduled for Monday, April 18
AQ
04/13GLOBAL MARKETS LIVE : LVMH, GSK, Twitter, Blackrock, Walmart...
04/13WALL STREET STOCK EXCHANGE : The confusion over inflation
04/13Novavax's COVID-19 Vaccine Wins Conditional Marketing Authorization in Switzerland
MT
04/13Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine
PR
04/13Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine
CI
04/13Novavax's Protein-based COVID-19 Vaccine Approved In Switzerland
MT
04/08Novavax COVID-19 Vaccine Granted Emergency Use Authorization for Adults in Thailand; Sh..
MT
04/08Novavax COVID-19 Vaccine Granted Emergency Use Authorization for Adults in Thailand; Sh..
MT
04/08Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' C..
PR
03/31Novavax Seeks to Expand Conditional Marketing Authorization of COVID-19 Vaccine in Euro..
MT
03/31Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vacci..
PR
03/31Novavax, Inc. Submits Request to Expand Conditional Marketing Authorization of COVID-19..
CI
03/31NOVAVAX : Statement on Arrival of its COVID-19 Vaccine in Canada
PU
03/30EMA Says Looking At Extension Of Novavax COVID Shot For Adolescents
RE
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on NOVAVAX, INC.